Abstract
Here we present a polycyclization of oxotriphenylhexanoates. The polycyclization is governed by electronic effects, and three major synthetic paths have been established leading to stereochemically complex tricyclic frameworks with up to five stereogenic centers. The method is compatible with an array of functional groups, allowing pharmacophoric elements to be introduced post cyclization.
Morphine,1 paclitaxel,2−4 strychnine,5 or polycyclic terpenes6,7 are some examples of natural polycyclic products containing a complex ring system with several stereogenic centers. Polycyclic compounds are interesting because they encode a high degree of molecular information that often makes them selective for a particular biological target. Additionally, polycycles, with a limited number of conformational states, suffer from less entropic loss in ligand binding, making them theoretically more potent binders.8 Therefore, construction of polycycles is a highly relevant objective in natural product synthesis and medicinal chemistry research.9−13 However, generally synthesis of polycycles is difficult and requires multistep synthesis.1−5,14−16 As a consequence most approaches are time-consuming and cost prohibitive, hampering true biological evaluation and, in the end, commercialization.17
A way to circumvent synthetic difficulties is to mimic nature and construct a stereospecific polycyclization event where several bonds are set in one step.18,19 One early example is the biomimetic polycyclization of progresterone reported by Johnson and co-workers.20 In their strategy, a polyolefinic substrate undergoes a stereospecific cyclization cascade to give the core four carbocyclic rings of progesterone. Since then, a number of cascade polycyclizations in natural product synthesis21,22 have been designed relying on dearomatizarion-driven,23 pericyclic,24−32 cationic,33−40 metal-catalyzed,41−48 and radical cascades.49−58 Inspired by these strategies, we began investigating the possibility for cyclizing the oxotriphenylhexanoate (OTHO) core. The OTHO is made in a diastereoselective highly modular multicomponent reaction providing a molecular core with two vicinal aryls oriented in an anti-relationship (Figure 1 top).59−62 Furthermore, the OTHO is in principle set up for several potential cyclizations with nucleophilic and electrophilic centers distributed five or six carbons apart normally optimal for cyclizations (such as the Dieckmann condensation between the α-carbon of the ketone and the ester) (Figure 1). However, we envisioned a design strategy that would start with initial formation of a six-membered ring through an intramolecular Friedel–Crafts-type addition of Ar3 on the aromatic ketone (red arrow) followed by elimination of the tertiary alcohol to yield olefin 5. In the next step the double bond undergoes a sequential Lewis activated acylation/aromatic addition to give polycyclic compound 3 (Figure 1 bottom). To evaluate this hypothesis the study commenced with initial screening of different Lewis acids for the cyclization of 1a. While most Lewis acids were inefficient in promoting the transformation (see ESI) BBr3 (1 equiv) proved to be the only productive Lewis acid delivering carbocycle 2a via a Dieckmann condensation in 65% yield (Table 1, entry 1). At a higher loading of BBr3 (3–5 equiv), a cascade of cyclizations took place and tricycle 3a could be isolated in 68–70% yield (entries 2 and 3). The fastest reaction and highest yield of 3a (75%) was observed when 10 equiv of BBr3 was used (entry 4). The reaction performs best in chlorinated solvents, and chloroform can also be used as a reaction solvent (entry 5).
Figure 1.
Design plan: two-step synthesis of complex polycycles from readily available starting materials.
Table 1. Lewis Acid Mediated Cyclization of 1a.
| entry | reagent | solvent | time (h) | conversion (%) | yield of 2a/3aa (%) |
|---|---|---|---|---|---|
| 1 | BBr3 (1 equiv) | DCM | 16 | 80 | 65/0 |
| 2 | BBr3 (3 equiv) | DCM | 16 | 100 | 0/68 |
| 3 | BBr3 (5 equiv) | DCM | 16 | 100 | 0/70 |
| 4 | BBr3 (10 equiv) | DCM | 10 | 100 | 0/75 |
| 5 | BBr3 (5 equiv) | CHCl3 | 16 | 100 | traces/50 |
| 6 | BBr3 (5 equiv) | MeCN | 12 | 100 | –/– |
Isolated yield. Reactions were carried out on 0.25 mmol scale of 1a in a solvent (3 mL) in a sealed reaction vessel at rt.
With our optimized conditions in hand, we first tested the efficiency of the domino reaction on a larger reaction scale. It was shown that the cyclization of 1a in 1 mmol scale proceeded with just a small loss of efficiency and the corresponding product 3a could be isolated in 72% yield (compared to 75% in standard 0.25 mmol reaction scale) (Figure 2). With these results in hand, the scope was explored. First, we examined the effect of substituents on Ar3 (Figure 2). To probe the compatibility with steric bulk, methyl groups were installed on all position of Ar3 in OTHO 1. It can be seen that Ar3 can be substituted on all positions to deliver tricycle 3 in generally excellent yield. For instance, methyl-substituted 3b can be isolated in 75% yield (which corresponds to 91% per bond formed). The most difficult substrate in the series was 1d with o-Me on Ar3. The low yield (30%) can be explained by a steric effect exerted by the Me in the ortho position and/or that only one of two possible aromatic carbons are available for bond forming. Halogen substituents are also tolerated, and chloro and bromo derivative 3f and 3g can be isolated in good yield (68% and 61%). Investigating the availability of the Ar2 shows a similar trend with methyl-substituted tetracycles 3h, 3i and 3j isolated in 47%, 51%, and 74% yield, respectively. For Ar1, both electron-rich and electron-poor substituents are tolerated. For instance, catechol derivative 3n could be isolated in 42% yield. In this transformation the BBr3 plays two roles, promoting the polycyclization and deprotection of the dimethylated catechol starting material. Ar1 halogens are also tolerated, and compounds 3o, 3p, 3q, and 3r can be isolated in 52%, 48%, 42%, and 63% yield. In the case of the latter tricyclic compounds dihydrochrysenone derivatives (4q–r) were isolated as side products. In the case of cyano (1s) and pyridinyl (1t) derivatives dihydrochrysenones 4s–t were the only products that could be isolated. The rest of the reaction mixture consisted of unidentified decomposed starting material.
Figure 2.
Scope of BBr3-mediated polycyclization of OTHO. Reactions were carried out on a 0.25 mmol scale of 1 in DCM (3 mL) in a sealed reaction vessel at rt. (a) 1 mmol scale reaction yield.
Mechanistically, this finding pointed toward that there are several reaction pathways operational which are under aromatic electronic control. Monitoring the reaction on a gas chromatograph, equipped with a flame ionization detector (GC–FID), showed that, as the OTHO was consumed, there was a buildup of an intermediate that in turn was consumed as the reaction progressed (Figure 3A, yellow line). Stopping the reaction prematurely at 10 min made it possible to isolate the intermediate, and we could determine the structure to be cyclohexene derivative 5. Intermediate 5 could also be observed in the reaction mixture by NMR (see the Supporting Information). To confirm the notion that 5 is the true intermediate product in the cyclization of 1a intermediate 5 was subjected to 10 equiv of BBr3 to provide 3a in 51% yield. These observations lead us to propose the following reaction mechanism (Figure 4). The reaction starts with an intramolecular Friedel–Crafts-type addition of Ar3 on the ketone (blue reaction arrow) followed by elimination of the tertiary alcohol to yield olefin 5 which can be followed by NMR. In the next step we propose a BBr3 activated acylation/aromatic addition to the double bond to yield the final compound 3. This is the general reaction pattern and occurs for compounds 3a–r. However, with electron-poor Ar1 the reactivity is drastically shifted with the double bond less prone to react with the ester. Instead an aromatic acylation occurs on Ar2 (red reaction arrow) forming the dihydrochrysenone derivatives (4q–s), whereas, when 2 was subjected to 10 equiv of BBr3 no reaction could be observed (Figure 3B). This finding clearly demonstrates that 2 is not an intermediate in the synthesis of 3.
Figure 3.
(A) Kinetic plot for the cyclization of 1a. (B) Possible intermediates.
Figure 4.
Plausible mechanism scheme for the polycyclization of OTHO leading to derivatives 3 and 4.
The attentive reader notices that only halogens in the meta position on Ar3 are represented in Figure 2 (entries 3f and 3g). The introduction of electron-withdrawing groups on the aromatic ring in the para and ortho position converts the OTHO into a totally different cyclic compound. This was clear after isolation as the 13C NMR was lacking the carbonyl peak. At first the structure of the unknown new product was puzzling considering the very strong effect that was achieved by the placement of the halogen in the starting material (meta vs para compare entries 3f, 6b and 3g, 6d). But after solving the structure by NMR and confirming that structure with single-crystal X-ray diffraction of compound 6b we could conclude that we have a new tricyclic compound having two bridgehead bromo-atoms. The yield for carbocycle 6 is generally good considering that five new bonds are being formed in this one-pot transformation and as a single stereoisomer. The scope was investigated, and the trend is that, as long as an electron withdrawing group is present para or ortho on Ar3 carbocycle 6 will form (Figure 5). For instance, OTHOs with a halogen substituted ortho or para on the aromatic ring will cyclize readily to form compound 6a–f in yields ranging from 46–76% yield. Electron withdrawing ester group will also cyclize to give derivative 6g in 35% yield. Interestingly, Ar3 methoxy substituted OTHOs also form carbocycle 6h. This is counterintuitive considering that the methoxy group through electron donation should facilitate the nucleophilic attack on the ketone in the first step. However, this might be an effect of BBr3 complexing the methoxy group or OH rendering it slightly electron poor thus facilitating the somewhat off-route reaction pattern. Notably, functional groups such as catechol, phenol (entries 3n and 6h) and aromatic carboxylic acid, the later easily derived from 4s or 6g, are common pharmacophores providing a step-economical approach to potentially active pharmaceutical ingredients.
Figure 5.
Scope of derivatives 6. Reactions were carried out on 0.25 mmol scale of 1 in DCM (3 mL) in a sealed reaction vessel at rt.
Mechanistically, we propose that the formation of 6 starts with a Friedel–Craft acylation occurring through a doubly BBr3 activated ketoester. In the first step a reaction between the more reactive nonsubstituted aromatic ring “2” and ester group leading to the formation of tetralone II occurs. Next a boron-mediated enol addition to the aromatic carbonyl forms carbocycle III. Following the reaction on GC shows that an intermediate builds up over time and reaches a maximum after 200 min (see ESI). We believe that this intermediate is derivative III, indirectly verified by NMR after prematurely quenching the reaction forming unsaturated olefinic species IV (Figure 6). In the next step, bromine is introduced through a BBr3 promoted substitution reaction to form V. The slightly larger equatorial bromo substituent forces the aromatic ring closer to the carbonyl and facilitates the attack on the ketone to render the final annulation (VI). Finally, 6 is formed through a BBr3 assisted substitution.63 Other domino halocyclizations using boron trihalides have been reported in for instance indene functionalizations64 and polycyclic aromatic hydrocarbon synthesis.65
Figure 6.
Proposed mechanism of polycyclization of OTHOs leading to derivatives 6.
The versatility of above prepared derivatives was demonstrated in the following sequence of transformation on dibromo derivatives 6. We showed that 6 could be orthogonally functionalized using the combination of radical and cross-coupling chemistry (Figure 7). Accordingly, treating 6f with allylmagnesium bromide in the presence of silver nitrate gave the corresponding bis-allylated product,66 which in turn was directly used in a palladium-catalyzed Suzuki cross-coupling reaction67 yielding the doubly functionalized compound 7 in 42% yield, over two steps, as a single diastereomer. Interestingly, the formation of radicals on the carbon framework does not seem to cause any fragmentation, suggesting that other radical reactions might also be suitable for functionalizing the dibromo-scaffold.
Figure 7.
Subsequent transformation of 6f.
In summary, a straightforward, step-economical route to complex tricyclic molecules with up to five stereogenic centers is presented. The BBr3 promoted stereoselective domino polycyclization relies on easily accessible starting materials (OTHOs) and is compatible with a range of modular aromatic substituents. A systematic investigation of the aromatic substitution pattern of the OTHOs shows that the cyclization is under aromatic electronic control directing the cyclization reaction to either tricyclic molecule 3 or bridgehead dibromo derivative 6. Both types of compound classes are difficult to prepare by any other known methodologies and can potentially be used to position functional groups in space vital, for instance, in the design of biologically active compounds. Lastly, we have also been able to show the possibility of subsequent transformations of polycycles demonstrating the synthetic utility of the protocol.
Acknowledgments
The Swedish Research Council Formas is gratefully acknowledged for funding. M.K. thanks the Operational Programme Research, Development and Education, project name: Improvement of internationalization in the field of research and development at Charles University, through the support of quality projects MSCA-IF (reg. no. CZ.02.2.69/0.0/0.0/17_050/0008466) for postdoctoral funding.
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.orglett.0c03020.
Experimental details and NMR spectra of synthesized compounds (PDF)
Accession Codes
CCDC 1989150–1989151 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, or by emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
The authors declare no competing financial interest.
Supplementary Material
References
- Gates M.; Tschudi G. J. Am. Chem. Soc. 1956, 78, 1380–1393. 10.1021/ja01588a033. [DOI] [Google Scholar]
- Nicolaou K. C.; Yang Z.; Liu J. J.; Ueno H.; Nantermet P. G.; Guy R. K.; Claiborne C. F.; Renaud J.; Couladouros E. A.; Paulvannan K.; Sorensen E. J. Nature 1994, 367, 630–634. 10.1038/367630a0. [DOI] [PubMed] [Google Scholar]
- Holton R. A.; Somoza C.; Kim H. B.; Liang F.; Biediger R. J.; Boatman P. D.; Shindo M.; Smith C. C.; Kim S. J. Am. Chem. Soc. 1994, 116, 1597–1598. 10.1021/ja00083a066. [DOI] [Google Scholar]
- Holton R. A.; Kim H. B.; Somoza C.; Liang F.; Biediger R. J.; Boatman P. D.; Shindo M.; Smith C. C.; Kim S. J. Am. Chem. Soc. 1994, 116, 1599–1600. 10.1021/ja00083a067. [DOI] [Google Scholar]
- Woodward R. B.; Cava M. P.; Ollis W. D.; Hunger A.; Daeniker H. U.; Schenker K. J. Am. Chem. Soc. 1954, 76, 4749–4751. 10.1021/ja01647a088. [DOI] [Google Scholar]
- Gershenzon J.; Dudareva N. Nat. Chem. Biol. 2007, 3, 408–414. 10.1038/nchembio.2007.5. [DOI] [PubMed] [Google Scholar]
- Hu P.; Chi H. M.; DeBacker K. C.; Gong X.; Keim J. H.; Hsu I. T.; Snyder S. A. Nature 2019, 569, 703–707. 10.1038/s41586-019-1179-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fang Z.; Song Y. n.; Zhan P.; Zhang Q.; Liu X. Future Med. Chem. 2014, 6, 885–901. 10.4155/fmc.14.50. [DOI] [PubMed] [Google Scholar]
- Schreiber S. L. Science 2000, 287, 1964–1969. 10.1126/science.287.5460.1964. [DOI] [PubMed] [Google Scholar]
- Galloway W. R. J. D.; Isidro-Llobet A.; Spring D. R. Nat. Commun. 2010, 1, 80. 10.1038/ncomms1081. [DOI] [PubMed] [Google Scholar]
- O’ Connor C. J.; Beckmann H. S. G.; Spring D. R. Chem. Soc. Rev. 2012, 41, 4444–4456. 10.1039/c2cs35023h. [DOI] [PubMed] [Google Scholar]
- Kuznetsov D. M.; Kutateladze A. G. J. Am. Chem. Soc. 2017, 139, 16584–16590. 10.1021/jacs.7b07598. [DOI] [PubMed] [Google Scholar]
- Plesniak M. P.; Garduño-Castro M. H.; Lenz P.; Just-Baringo X.; Procter D. J. Nat. Commun. 2018, 9, 4802. 10.1038/s41467-018-07194-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Corey E. J.; Desai M. C.; Engler T. A. J. Am. Chem. Soc. 1985, 107, 4339–4341. 10.1021/ja00300a049. [DOI] [Google Scholar]
- Bonjoch J.; Solé D. Chem. Rev. 2000, 100, 3455–3482. 10.1021/cr9902547. [DOI] [PubMed] [Google Scholar]
- Lee H.; Kang T.; Lee H.-Y. Angew. Chem., Int. Ed. 2017, 56, 8254–8257. 10.1002/anie.201704492. [DOI] [PubMed] [Google Scholar]
- Nicolaou K. C.; Sorensen E. J.. Classics in Total Synthesis: Targets, Strategies, Methods; Wiley, 1996. [Google Scholar]
- Tietze L. F. Chem. Rev. 1996, 96, 115–136. 10.1021/cr950027e. [DOI] [PubMed] [Google Scholar]
- Tietze L. F.; Brasche G.; Gericke K. M.. Domino Reactions in Organic Synthesis; Wiley-VCH, 2006. [Google Scholar]
- Johnson W. S. Angew. Chem., Int. Ed. Engl. 1976, 15, 9–17. 10.1002/anie.197600091. [DOI] [PubMed] [Google Scholar]
- Anderson E. A. Org. Biomol. Chem. 2011, 9, 3997–4006. 10.1039/c1ob05212h. [DOI] [PubMed] [Google Scholar]
- Ardkhean R.; Caputo D. F. J.; Morrow S. M.; Shi H.; Xiong Y.; Anderson E. A. Chem. Soc. Rev. 2016, 45, 1557–1569. 10.1039/C5CS00105F. [DOI] [PubMed] [Google Scholar]
- Powers Z.; Scharf A.; Cheng A.; Yang F.; Himmelbauer M.; Mitsuhashi T.; Barra L.; Taniguchi Y.; Kikuchi T.; Fujita M.; Abe I.; Porco J. A. Jr Angew. Chem., Int. Ed. 2019, 58, 16141–16146. 10.1002/anie.201910710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shishido K.; Shitara E.; Komatsu H.; Hiroya K.; Fukumoto K.; Kametani T. J. Org. Chem. 1986, 51, 3007–3011. 10.1021/jo00365a029. [DOI] [Google Scholar]
- Danishefsky S. J.; DeNinno M. P. Angew. Chem., Int. Ed. Engl. 1987, 26, 15–23. 10.1002/anie.198700151. [DOI] [Google Scholar]
- Mikami K.; Takahashi K.; Nakai T. J. Am. Chem. Soc. 1990, 112, 4035–4037. 10.1021/ja00166a049. [DOI] [Google Scholar]
- Knight S. D.; Overman L. E.; Pairaudeau G. J. Am. Chem. Soc. 1993, 115, 9293–9294. 10.1021/ja00073a057. [DOI] [Google Scholar]
- Angle S. R.; Fevig J. M.; Knight S. D.; Marquis R. W.; Overman L. E. J. Am. Chem. Soc. 1993, 115, 3966–3976. 10.1021/ja00063a016. [DOI] [Google Scholar]
- Denmark S. E.; Thorarensen A. J. Org. Chem. 1994, 59, 5672–5680. 10.1021/jo00098a027. [DOI] [Google Scholar]
- Mikami K.; Takahashi K.; Nakai T.; Uchimaru T. J. Am. Chem. Soc. 1994, 116, 10948–10954. 10.1021/ja00103a009. [DOI] [Google Scholar]
- Deng W.; Overman L. E. J. Am. Chem. Soc. 1994, 116, 11241–11250. 10.1021/ja00104a005. [DOI] [Google Scholar]
- Poulin J.; Grisé-Bard C. M.; Barriault L. Chem. Soc. Rev. 2009, 38, 3092–3101. 10.1039/b819798a. [DOI] [PubMed] [Google Scholar]
- Jacobsen E. J.; Levin J.; Overman L. E. J. Am. Chem. Soc. 1988, 110, 4329–4336. 10.1021/ja00221a037. [DOI] [Google Scholar]
- O’Hagan D. Nat. Prod. Rep. 1989, 6, 205–219. 10.1039/np9890600205. [DOI] [PubMed] [Google Scholar]
- Bartlett W. R.; Johnson W. S.; Plummer M. S.; Small V. R. J. Org. Chem. 1990, 55, 2215–2224. 10.1021/jo00294a043. [DOI] [Google Scholar]
- Snowden R. L.; Eichenberger J. C.; Linder S. M.; Sonnay P.; Vial C.; Schulte-Elte K. H. J. Org. Chem. 1992, 57, 955–960. 10.1021/jo00029a031. [DOI] [Google Scholar]
- Fish P. V.; Johnson W. S. J. Org. Chem. 1994, 59, 2324–2335. 10.1021/jo00088a011. [DOI] [Google Scholar]
- Beifuss U.; Ledderhose S. Synlett 1995, 1995, 938–940. 10.1055/s-1995-5114. [DOI] [Google Scholar]
- Koert U. Angew. Chem., Int. Ed. Engl. 1995, 34, 298–300. 10.1002/anie.199502981. [DOI] [Google Scholar]
- Barrett T. N.; Barrett A. G. M. J. Am. Chem. Soc. 2014, 136, 17013–17015. 10.1021/ja511534x. [DOI] [PubMed] [Google Scholar]
- Dombroski M. A.; Kates S. A.; Snider B. B. J. Am. Chem. Soc. 1990, 112, 2759–2767. 10.1021/ja00163a044. [DOI] [Google Scholar]
- Porco J. A.; Schoenen F. J.; Stout T. J.; Clardy J.; Schreiber S. L. J. Am. Chem. Soc. 1990, 112, 7410–7411. 10.1021/ja00176a060. [DOI] [Google Scholar]
- Dauben W. G.; Dinges J.; Smith T. C. J. Org. Chem. 1993, 58, 7635–7637. 10.1021/jo00079a004. [DOI] [Google Scholar]
- Boyer F.-D.; Hanna I.; Ricard L. Org. Lett. 2004, 6, 1817–1820. 10.1021/ol049452x. [DOI] [PubMed] [Google Scholar]
- Pinto A.; Jia Y.; Neuville L.; Zhu J. Chem. - Eur. J. 2007, 13, 961–967. 10.1002/chem.200601016. [DOI] [PubMed] [Google Scholar]
- Mai W.-P.; Sun G.-C.; Wang J.-T.; Song G.; Mao P.; Yang L.-R.; Yuan J.-W.; Xiao Y.-M.; Qu L.-B. J. Org. Chem. 2014, 79, 8094–8102. 10.1021/jo501301t. [DOI] [PubMed] [Google Scholar]
- Hao T.-T.; Liang H.-R.; Ou-Yang Y.-H.; Yin C.-Z.; Zheng X.-L.; Yuan M.-L.; Li R.-X.; Fu H.-Y.; Chen H. J. Org. Chem. 2018, 83, 4441–4454. 10.1021/acs.joc.8b00150. [DOI] [PubMed] [Google Scholar]
- Pellissier H. Adv. Synth. Catal. 2019, 361, 1733–1755. 10.1002/adsc.201801371. [DOI] [Google Scholar]
- Corey E. J.; Kang M. C. J. Am. Chem. Soc. 1984, 106, 5384–5385. 10.1021/ja00330a076. [DOI] [Google Scholar]
- Fevig T. L.; Elliott R. L.; Curran D. P. J. Am. Chem. Soc. 1988, 110, 5064–5067. 10.1021/ja00223a026. [DOI] [Google Scholar]
- Curran D. P.; Liu H. J. Am. Chem. Soc. 1992, 114, 5863–5864. 10.1021/ja00040a060. [DOI] [Google Scholar]
- Hitchcock S. A.; Pattenden G. Tetrahedron Lett. 1992, 33, 4843–4846. 10.1016/S0040-4039(00)61300-X. [DOI] [Google Scholar]
- Chen L.; Gill G. B.; Pattenden G. Tetrahedron Lett. 1994, 35, 2593–2596. 10.1016/S0040-4039(00)77180-2. [DOI] [Google Scholar]
- Takahashi T.; Katouda W.; Sakamoto Y.; Tomida S.; Yamada H. Tetrahedron Lett. 1995, 36, 2273–2276. 10.1016/0040-4039(95)00269-I. [DOI] [Google Scholar]
- Sebren L. J.; Devery J. J.; Stephenson C. R. J. ACS Catal. 2014, 4, 703–716. 10.1021/cs400995r. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Plesniak M. P.; Huang H.-M.; Procter D. J. Nat. Rev. Chem. 2017, 1, 0077. 10.1038/s41570-017-0077. [DOI] [Google Scholar]
- Wang X.; Xia D.; Qin W.; Zhou R.; Zhou X.; Zhou Q.; Liu W.; Dai X.; Wang H.; Wang S.; Tan L.; Zhang D.; Song H.; Liu X.-Y.; Qin Y. Chem. 2017, 2, 803–816. 10.1016/j.chempr.2017.04.007. [DOI] [Google Scholar]
- Hung K.; Hu X.; Maimone T. J. Nat. Prod. Rep. 2018, 35, 174–202. 10.1039/C7NP00065K. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nair V.; Babu B. P.; Vellalath S.; Varghese V.; Raveendran A. E.; Suresh E. Org. Lett. 2009, 11, 2507–2510. 10.1021/ol900571x. [DOI] [PubMed] [Google Scholar]
- Ta L.; Axelsson A.; Bijl J.; Haukka M.; Sunden H. Chem. - Eur. J. 2014, 20, 13889–13893. 10.1002/chem.201404288. [DOI] [PubMed] [Google Scholar]
- Axelsson A.; Ta L.; Sunden H. Catalysts 2015, 5, 2052–2067. 10.3390/catal5042052. [DOI] [Google Scholar]
- Sauvée C.; Ström A.; Haukka M.; Sundén H. Chem. - Eur. J. 2018, 24, 8071–8075. 10.1002/chem.201800635. [DOI] [PubMed] [Google Scholar]
- Pelletier J. D.; Poirier D. Tetrahedron Lett. 1994, 35, 1051–1054. 10.1016/S0040-4039(00)79963-1. [DOI] [Google Scholar]
- Sultana S.; Lee Y. R. Adv. Synth. Catal. 2020, 362, 927–941. 10.1002/adsc.201901266. [DOI] [Google Scholar]
- Yuan K.; Kahan R. J.; Si C.; Williams A.; Kirschner S.; Uzelac M.; Zysman-Colman E.; Ingleson M. J. Chem. Sci. 2020, 11, 3258–3267. 10.1039/C9SC05404A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Someya H.; Ohmiya H.; Yorimitsu H.; Oshima K. Org. Lett. 2008, 10, 969–971. 10.1021/ol800038a. [DOI] [PubMed] [Google Scholar]
- Bower J. F.; Guillaneux D.; Nguyen T.; Wong P. L.; Snieckus V. J. Org. Chem. 1998, 63, 1514–1518. 10.1021/jo971771x. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.









